Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediRama is a South Korean CDRO specializing in clinical development strategy and operations for pharmaceutical and biotech companies. It has particular expertise in oncology drug development and regulatory pathways including FDA Accelerated Approval, Fast Track, Breakthrough Therapy, and Priority Review. The company collaborates with global partners to accelerate drug development timelines—especially for US/EU biotechs entering Asia—and provides consulting services to optimize clinical plans. MediRama does not commercialize its own products but enables successful NDA/BLA submissions for clients’ compounds[2][4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediRama.